AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Cohort SURVI : Intestinal Ischemia and Vascular Diseases

Recruitingn/aAges 18 Years - anyAllAssistance Publique - Hรดpitaux de Paris
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The first Intestinal Vascular Emergency Unit (SURVI), with the institutional support of AP-HP, opened on 4 January 2016, within the Paris-Nord Val de Seine University Hospital Group. This intensive care is dedicated to the management of mesenteric ischemias (acute mesenteric ischemias, chronic mesenteric ischemias) and Intestinal Vascular Diseases Without Ischemia. The organisation of this type of dedicated centre, combining advances in resuscitation, interventional radiology and knowledge of intestinal vascular diseases, has led to a radical change in the prognosis for acute mesenteric ischaemia with a survival rate of over 80% and an intestinal resection rate of less than 40%. Acute mesenteric ischaemia (AMI) is characterised by the combination of digestive distress and vascular insufficiency: occlusive (thrombosis, embolism, arterial, venous) or non-occlusive (low flow or vasospasm).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age \> 18 years old * IMVI including : * acute mesenteric ischaemia defined by acute digestive distress in relation to arterial and/or venous, occlusive and/or non-occlusive splanchnic-mesenteric vascular insufficiency, in the absence of an alternative diagnosis * Chronic mesenteric ischaemia defined by chronic digestive distress (duration of symptom evolution \>30 days) related to occlusive or non- occlusive arterial or venous vascular insufficiency. * MVI: gastrointestinal arterial or venous diseases without ischaemia (atheroma, embolism, thrombosis, dissection, mediolysis, aneurysm, dysplasia, sheathing, compression, torsion) Exclusion Criteria: * Left ischaemic colitis without damage to the celiac trunk and/or superior mesenteric artery * Dissection of the abdominal aorta without intestinal ischaemia * Portal thrombosis without extension to the superior mesenteric vein * Portal thrombosis without extension to the superior mesenteric vein * Traumatic rupture of the digestive arteries * Non-injected abdominal scanner or no abdominal scanner * Patient opposition to participation in research * Patient under guardianship / curators * Vulnerable patient: pregnant or breastfeeding women, persons deprived of their liberty, minors, adults unable or unwilling to give consent
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Olivier CORCOS
Clichy, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy